According to a market report by Lucintel, the future of the global corneal cross linking device market looks promising with opportunities in the hospital, eye clinic, and ambulaotory surgery center markets. The global corneal cross linking device market is expected to reach an estimated $1 billion by 2030 at a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are increased prevalence of keratoconus and rising demand for advanced linking devices to improve patient comfort.
A more
than 150-page report to understand trends, opportunity and forecast in global
corneal cross linking device market to 2030 by type (standard corneal
cross-linking, corneal cross-linking plus, and accelerated cross-linking),
method (epithelium-off method and epithelium-on method), application
(keratoconus, pellucid marginal degeneration, refractive surgery ectasia, and
others), end use (hospitals, ambulatory surgical centers, eye clinics, and
others), and region (North America, Europe, Asia Pacific, and the Rest of the
World).
Lucintel
forecasts that standard corneal cross-linking is expected to witness highest
growth over the forecast period.
Hospital
is expected to witness highest growth over the forecast period.
Download
sample by clicking on corneal
cross linking device market.
APAC is
expected to witness highest growth over the forecast period due to existence of
robust healthcare infrastructure and presence of major customer base in the
region.
Glaukos,
EMAGine, Peschke, IROMED, IVIS Technologies, AJL Ophthalmic are the major
suppliers in the corneal cross
linking device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Bentonite Nano Clay Powder Market
Coenzyme Q10 Nano-Emulsion Market
Horizontal Nano Bead Mill Market
Nano Bismuth Oxide Powder Market
No comments:
Post a Comment